Adverum Biotechnologies Appoints Andrew Ramelmeier, Ph.D. as

Adverum Biotechnologies Appoints Andrew Ramelmeier, Ph.D. as Chief Technology Officer

Adverum Biotechnologies Appoints Andrew Ramelmeier, Ph.D. as Chief Technology Officer

itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Berkeley , California , United States , R Andrew Andy Ramelmeier , Anand Reddi , Peter Soparkar , Nasdaq , Exchange Commission , Johnson , Merck Research Laboratories , Adverum Biotechnologies Inc , Institute Of Enzyme Technology , Biomarin Pharmaceuticals , Portola Pharmaceuticals , Johns Hopkins University , University Of California , Adverum Biotechnologies , Sangamo Therapeutics , Merck Research , Chemical Engineering , Enzyme Technology , Nasdaq Rule , Nasdaq Stock Market , Private Securities Litigation Reform Act , Quarterly Report , Corporate Strategy , External Affairs ,